SERPINF1 and neoplasm: While we provide evidence of the anticancer effects of PEDF in our cell-based models, future studies in vivo preclinical models are needed as only in such models can the true nature of complex tumours, inclusive of such things as vascularity, immune cells, and progression of a tumour in 3-dimension, be used to truly test the anticancer nature of promising agents such as PEDF.